
Welspun Specialty Q1 Results FY27: Swings to Rs 5.2 Crore Profit as EBITDA Margin More Than Doubles
Welspun Specialty Q1 FY27: net profit Rs 5.2 Cr vs loss of Rs 0.75 Cr. Revenue down 3.9% at Rs 194 Cr. EBITDA up to Rs 10.6 Cr, margin 5.5% vs 2.1%. Stock up 2.61% at Rs 54.28.
Updated: 21 Jul 2026 • 4:04 pm
Posted by:

Welspun Specialty Q1 results FY27 were announced on Tuesday, 21 July 2026, with the company reporting the numbers summarised below on a standalone basis for the quarter ended 30 June 2026.
Shares of Welspun Specialty rose 2.61 to Rs 54.28 on the NSE on the results day. The company makes specialty and stainless steel products, and the quarter marks a clean swing from loss to profit.
Click Here – Get Free Investment Predictions
Welspun Specialty Q1 Results FY27 Key Takeaways
Here are the most important numbers from the Welspun Specialty Q1 results FY27 at a glance.
- Revenue: Rs 194 Cr in Q1 FY27 versus Rs 201 Cr in Q1 FY26, down 3.9% year on year.
- EBITDA: Rs 10.6 Cr in Q1 FY27 versus Rs 4.3 Cr in Q1 FY26, up sharply year on year.
- Net Profit: Rs 5.2 Cr in Q1 FY27, a turnaround from a loss of Rs 0.75 crore in Q1 FY26.
- Welspun Specialty share price rose 2.61 to Rs 54.28 on the NSE on the results day.
Welspun Specialty Q1 Results FY27 Financial Highlights
The table below summarises the standalone numbers reported in the Welspun Specialty Q1 results FY27 against the year ago quarter.
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | Rs 194 Cr | Rs 201 Cr | -3.9% |
| EBITDA | Rs 10.6 Cr | Rs 4.3 Cr | +146.5% |
| Net Profit (PAT) | Rs 5.2 Cr | -Rs 0.75 Cr (loss) | Turnaround |
All figures are on a standalone basis as reported for the quarter ended 30 June 2026.
Welspun Specialty Q1 Results FY27 Performance Analysis
Get Personalised Guidance from a SEBI-Registered Investment Advisor
The Welspun Specialty Q1 results FY27 show a business turning profitable on a smaller revenue base, which is the more demanding way to improve earnings. EBITDA more than doubled to Rs 10.6 crore from Rs 4.3 crore even as revenue fell 3.9% to Rs 194 crore, and the EBITDA margin jumped to 5.5% from 2.1%.
Margin expansion despite a revenue decline in the Welspun Specialty Q1 results FY27 points to a genuine cost and mix improvement rather than volume driven profit, likely from a shift toward higher value specialty grades or better raw material cost management during the quarter.
A single profitable quarter after a loss is an important signal but not yet a trend. The company will need to repeat this performance in the September quarter before the turnaround can be considered structural.
Welspun Specialty Q1 Results FY27: Key Business Factors
1. Margin Led Turnaround
EBITDA margin more than doubling to 5.5% while revenue fell shows the swing to profit came from cost efficiency and product mix, not from selling more.
2. Revenue Softness to Watch
A 3.9% revenue decline, even in a profitable quarter, means volume or realisation headwinds have not fully faded.
3. Early Innings of the Recovery
With only one profitable quarter on record, the durability of the turnaround remains the single most important variable for investors to track.
Dividend Details
Any dividend announcement accompanying the June 2026 quarter results will be reflected in the company’s official NSE and BSE filings. Investors should rely on those filings for dividend confirmation rather than secondary sources.
Welspun Specialty Q1 Results FY27 Outlook for the Full Year
After the Welspun Specialty Q1 results FY27, the key question is whether the margin gains can be sustained as revenue stabilises or recovers. A repeat profitable quarter in September, ideally alongside a return to revenue growth, would confirm the turnaround is more than a one-off.
Welspun Specialty Stock Performance After the Q1 Results
Download the Univest iOS App or Univest Android App to track Welspun Specialty live share price and upcoming quarterly results.
Welspun Specialty share price rose 2.61 to Rs 54.28 on the NSE after the Welspun Specialty Q1 results FY27, as the market weighed the quarter’s numbers.
Investors can compare the trend of the counter with the Nifty Metal index to judge how the stock is placed relative to the broader market after the Welspun Specialty Q1 results FY27.
Key Risks
Investors going through the fine print of the Welspun Specialty Q1 results FY27 should also weigh the following risks.
1. Turnaround Durability
One profitable quarter does not confirm a trend. A repeat loss in the September quarter would undercut the recovery narrative.
2. Revenue Decline
The 3.9% fall in revenue needs to reverse for the turnaround to be considered complete rather than a cost cutting exercise.
3. Smallcap Volatility
As a smaller steel counter, the stock can see sharp price swings on modest news flow or low trading volumes.
Conclusion
Welspun Specialty Q1 results FY27 show a clean swing to profit at Rs 5.2 crore, with EBITDA margin more than doubling to 5.5% even as revenue slipped 3.9%. The quarter is an encouraging first step, and the September print will show whether the turnaround holds. Investors should verify the filings on NSE and BSE and consult a SEBI-registered advisor before acting on the numbers.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Welspun Specialty Q1 Results FY27
When were the Welspun Specialty Q1 results FY27 announced?
Ans. The Welspun Specialty Q1 results FY27 were announced on Tuesday, 21 July 2026, for the quarter ended 30 June 2026, on a standalone basis.
What is the PAT in the Welspun Specialty Q1 results FY27?
Ans. The standalone PAT in the Welspun Specialty Q1 results FY27 stood at Rs 5.2 crore, a turnaround from a loss of Rs 0.75 crore in Q1 FY26.
What was the revenue in the Welspun Specialty Q1 results FY27?
Ans. Revenue in the Welspun Specialty Q1 results FY27 stood at Rs 194 crore, down 3.9% from Rs 201 crore in Q1 FY26.
What was the EBITDA in the Welspun Specialty Q1 results FY27?
Ans. EBITDA in the Welspun Specialty Q1 results FY27 stood at Rs 10.6 crore against Rs 4.3 crore in Q1 FY26, with the EBITDA margin expanding to 5.5% from 2.1%.
How did the share price react to the Welspun Specialty Q1 results FY27?
Ans. Welspun Specialty share price rose 2.61% to Rs 54.28 on the NSE after the Welspun Specialty Q1 results FY27.
Is the stock a good buy after the Welspun Specialty Q1 results FY27?
Ans. The Welspun Specialty Q1 results FY27 show an encouraging turnaround, but a single profitable quarter on falling revenue needs follow through. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.
What does Welspun Specialty Solutions make?
Ans. The company produces specialty and stainless steel products.
Where can I verify the Welspun Specialty Q1 results FY27?
Ans. The official filings for the June 2026 quarter are available on the NSE and BSE websites, and the stock can be tracked on the Univest app.
Recent Articles

Sundaram Long Term Tax Advantage Fund Series IV vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
21 July 2026

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series IV: NAV, Returns and Maturity Status Compared
21 July 2026

Sundaram Long Term Tax Advantage Fund Series II vs SBI Series IV: NAV, Returns and Maturity Status Compared
21 July 2026

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series VI: NAV, Returns and Maturity Status Compared
21 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sundaram Long Term Tax Advantage Fund Series IV vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series III vs UTI Series IV: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series II vs SBI Series IV: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series III vs UTI Series VI: NAV, Returns and Maturity Status Compared
UTI Long Term Advantage Fund Series III vs Sundaram Micro Cap Series III Regular: NAV, Returns and Maturity Status Compared
Popular this week
Sundaram Long Term Tax Advantage Fund Series IV vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series III vs UTI Series IV: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series II vs SBI Series IV: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series III vs UTI Series VI: NAV, Returns and Maturity Status Compared
UTI Long Term Advantage Fund Series III vs Sundaram Micro Cap Series III Regular: NAV, Returns and Maturity Status Compared

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





